Intellia Therapeutics Inc buy Wells Fargo & Company
Start price
18.11.24
/
50%
€13.35
Target price
18.11.25
€66.07
Performance (%)
-26.83%
Price
26.08.25
€9.76
Summary
This prediction is currently active. The price of Intellia Therapeutics Inc has decreased since the start of the prediction. Compared to the start price this results in a performance of -26.83%. This prediction currently runs until 18.11.25. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Intellia Therapeutics Inc | 6.570% | 6.570% |
iShares Core DAX® | -0.347% | -0.149% |
iShares Nasdaq 100 | -0.687% | 1.850% |
iShares Nikkei 225® | -2.075% | 3.770% |
iShares S&P 500 | 0.351% | 1.988% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics, Inc. (NASDAQ: NTLA) had its price target lowered by analysts at Wells Fargo & Company from $80.00 to $70.00. They now have an "overweight" rating on the stock.
Ratings data for NTLA provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€9.49
08.08.25
08.08.25
-
08.08.26
08.08.26
2.91%
26.08.25
26.08.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€9.50
28.02.25
28.02.25
€48.09
28.02.26
28.02.26
2.78%
26.08.25
26.08.25
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€10.22
10.01.25
10.01.25
€58.40
10.01.26
10.01.26
-4.46%
26.08.25
26.08.25